These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 9002296)
21. Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic rats. Choi KC; Lee SC; Kim SW; Kim NH; Lee JU; Kang YJ Korean J Intern Med; 1999 Jan; 14(1):32-41. PubMed ID: 10063312 [TBL] [Abstract][Full Text] [Related]
22. Nitric oxide-dependent renal vasodilatation is not altered in rat with rHuEpo-induced hypertension. Migliori M; Taccola D; Panichi V; De Pietro S; Andreini B; Di Benedetto A; Filippi C; Palla R; Giovannini L Kidney Blood Press Res; 1999; 22(3):140-5. PubMed ID: 10394113 [TBL] [Abstract][Full Text] [Related]
23. Detrimental effects of nitric oxide on mesenteric circulation during endotoxaemia and its reversal by aminoguanidine. Yorganci K; Sayek I; Ismailoglu UB; Sahin-Erdemli I Eur J Surg; 2000 Nov; 166(11):888-93. PubMed ID: 11097157 [TBL] [Abstract][Full Text] [Related]
24. Effects of aminoguanidine on nitric oxide production induced by inflammatory cytokines and endotoxin in cultured rat hepatocytes. Zhang GL; Wang YH; Teng HL; Lin ZB World J Gastroenterol; 2001 Jun; 7(3):331-4. PubMed ID: 11819785 [TBL] [Abstract][Full Text] [Related]
26. Experiments with nitric oxide synthase inhibitors in spinal nerve ligated rats provide no evidence of a role for nitric oxide in neuropathic mechanical allodynia. Lee DH; Singh JP; Lodge D Neurosci Lett; 2005 Sep; 385(3):179-83. PubMed ID: 15964141 [TBL] [Abstract][Full Text] [Related]
27. Relative contributions of advanced glycation and nitric oxide synthase inhibition to aminoguanidine-mediated renoprotection in diabetic rats. Soulis T; Cooper ME; Sastra S; Thallas V; Panagiotopoulos S; Bjerrum OJ; Jerums G Diabetologia; 1997 Oct; 40(10):1141-51. PubMed ID: 9349594 [TBL] [Abstract][Full Text] [Related]
28. Comparison of responses to aminoguanidine and N omega-nitro-L-arginine methyl ester in the rat aorta. Yen MH; Chen SJ; Wu CC Clin Exp Pharmacol Physiol; 1995 Sep; 22(9):641-5. PubMed ID: 8542678 [TBL] [Abstract][Full Text] [Related]
29. Glomerulosclerosis in the diet-induced obesity model correlates with sensitivity to nitric oxide inhibition but not glomerular hyperfiltration or hypertrophy. Polichnowski AJ; Licea-Vargas H; Picken M; Long J; Bisla R; Williamson GA; Bidani AK; Griffin KA Am J Physiol Renal Physiol; 2015 Nov; 309(9):F791-9. PubMed ID: 26109088 [TBL] [Abstract][Full Text] [Related]
30. Urinary NO3- excretion as an indicator of nitric oxide formation in vivo during oral administration of L-arginine or L-name in rats. Boger RH; Bode-Boger SM; Gerecke U; Gutzki FM; Tsikas D; Frolich JC Clin Exp Pharmacol Physiol; 1996 Jan; 23(1):11-5. PubMed ID: 8713490 [TBL] [Abstract][Full Text] [Related]
31. Manipulation of the L-arginine-nitric oxide pathway in airway inflammation induced by diesel exhaust particles in mice. Takano H; Lim HB; Miyabara Y; Ichinose T; Yoshikawa T; Sagai M Toxicology; 1999 Nov; 139(1-2):19-26. PubMed ID: 10614685 [TBL] [Abstract][Full Text] [Related]
32. Effect of nitric oxide synthase inhibitors on lipid peroxide formation in liver caused by endotoxin challenge. Sakaguchi S; Furusawa S; Yokota K; Sasaki K; Takayanagi M; Takayanagi Y Pharmacol Toxicol; 2000 Apr; 86(4):162-8. PubMed ID: 10815749 [TBL] [Abstract][Full Text] [Related]
33. Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension. Sigmon DH; Beierwaltes WH Hypertension; 1998 Feb; 31(2):649-56. PubMed ID: 9461236 [TBL] [Abstract][Full Text] [Related]
34. Comparative effects of selective and non-selective nitric oxide synthase inhibition in gentamicin-induced rat nephrotoxicity. Ghaznavi R; Kadkhodaee M Arch Toxicol; 2007 Jun; 81(6):453-7. PubMed ID: 17039356 [TBL] [Abstract][Full Text] [Related]
36. Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction. Banting JD; Friberg P; Adams MA J Hypertens; 1996 Aug; 14(8):975-81. PubMed ID: 8884552 [TBL] [Abstract][Full Text] [Related]
37. Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats. Ying L; Flamant M; Vandermeersch S; Boffa JJ; Chatziantoniou C; Dussaule JC; Chansel D Hypertension; 2003 Nov; 42(5):937-44. PubMed ID: 14569001 [TBL] [Abstract][Full Text] [Related]
38. Selective inhibition of inducible nitric oxide in ischemia-reperfusion of rat small intestine. Chen JC; Chen HM; Shyr MH; Fan LL; Chi TY; Chi CP; Chen MF J Formos Med Assoc; 2000 Mar; 99(3):213-8. PubMed ID: 10820953 [TBL] [Abstract][Full Text] [Related]
39. [Mechanism mediating hypertension induced by chronic inhibition of nitric oxide synthesis]. Li X; Yuasa S; Hitomi H; Hashimoto M; Fujioka H; Kiyomoto H; Uchida K; Shoji T; Takahashi N; Matsuo H Nihon Jinzo Gakkai Shi; 1997 Oct; 39(7):718-27. PubMed ID: 9396239 [TBL] [Abstract][Full Text] [Related]
40. Superoxide contributes to development of salt sensitivity and hypertension induced by nitric oxide deficiency. Kopkan L; Majid DS Hypertension; 2005 Oct; 46(4):1026-31. PubMed ID: 16103275 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]